These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31658375)

  • 1. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
    Baldwin LM; Coronado GD; West II; Schwartz MR; Meenan RT; Vollmer WM; Petrik AF; Shapiro JA; Kulkarni-Sharma YR; Green BB
    Cancer; 2022 Jan; 128(2):410-418. PubMed ID: 34586630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
    Green BB; West II; Baldwin LM; Schwartz MR; Coury J; Coronado GD
    J Community Health; 2020 Oct; 45(5):916-921. PubMed ID: 32219712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health plan adaptations to a mailed outreach program for colorectal cancer screening among Medicaid and Medicare enrollees: the BeneFIT study.
    Coronado GD; Schneider JL; Green BB; Coury JK; Schwartz MR; Kulkarni-Sharma Y; Baldwin LM
    Implement Sci; 2020 Sep; 15(1):77. PubMed ID: 32933525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
    Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
    BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
    Green BB; Baldwin LM; West II; Schwartz M; Coronado GD
    J Prim Care Community Health; 2020; 11():2150132720958525. PubMed ID: 32912056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members.
    Meenan RT; Baldwin LM; Coronado GD; Schwartz M; Coury J; Petrik AF; West II; Green BB
    Popul Health Manag; 2021 Apr; 24(2):255-265. PubMed ID: 32609077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.
    Davis MM; Coury J; Larson JH; Gunn R; Towey EG; Ketelhut A; Patzel M; Ramsey K; Coronado GD
    J Rural Health; 2023 Jan; 39(1):279-290. PubMed ID: 35703582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees.
    Davis MM; Nambiar S; Mayorga ME; Sullivan E; Hicklin K; O'Leary MC; Dillon K; Hassmiller Lich K; Gu Y; Lind BK; Wheeler SB
    Prev Med; 2019 Dec; 129S():105836. PubMed ID: 31635848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
    Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
    Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.
    Coury JK; Schneider JL; Green BB; Baldwin LM; Petrik AF; Rivelli JS; Schwartz MR; Coronado GD
    Transl Behav Med; 2020 Feb; 10(1):68-77. PubMed ID: 30445511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cost-effectiveness of mailed fecal immunochemical testing (FIT)-based interventions for increasing colorectal cancer screening in the Medicaid population.
    Wheeler SB; O'Leary MC; Rhode J; Yang JY; Drechsel R; Plescia M; Reuland DS; Brenner AT
    Cancer; 2020 Sep; 126(18):4197-4208. PubMed ID: 32686116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.
    Coronado GD; Leo MC; Ramsey K; Coury J; Petrik AF; Patzel M; Kenzie ES; Thompson JH; Brodt E; Mummadi R; Elder N; Davis MM
    Implement Sci Commun; 2022 Apr; 3(1):42. PubMed ID: 35418107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.
    Gupta S; Coronado GD; Argenbright K; Brenner AT; Castañeda SF; Dominitz JA; Green B; Issaka RB; Levin TR; Reuland DS; Richardson LC; Robertson DJ; Singal AG; Pignone M
    CA Cancer J Clin; 2020 Jul; 70(4):283-298. PubMed ID: 32583884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.